PGGM Investments Sells 14,261 Shares of Xylem Inc. (NYSE:XYL)

PGGM Investments cut its stake in Xylem Inc. (NYSE:XYLFree Report) by 65.4% in the 4th quarter, Holdings Channel reports. The firm owned 7,547 shares of the industrial products company’s stock after selling 14,261 shares during the period. PGGM Investments’ holdings in Xylem were worth $863,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. Commonwealth Equity Services LLC grew its holdings in shares of Xylem by 0.9% during the 3rd quarter. Commonwealth Equity Services LLC now owns 69,566 shares of the industrial products company’s stock worth $6,333,000 after acquiring an additional 645 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in Xylem by 16.0% during the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 40,539 shares of the industrial products company’s stock valued at $3,690,000 after buying an additional 5,600 shares during the period. Garrison Asset Management LLC boosted its holdings in shares of Xylem by 0.5% during the 3rd quarter. Garrison Asset Management LLC now owns 21,248 shares of the industrial products company’s stock valued at $1,934,000 after buying an additional 116 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its position in shares of Xylem by 3.1% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 18,603 shares of the industrial products company’s stock worth $1,693,000 after buying an additional 553 shares during the period. Finally, Xponance Inc. lifted its position in Xylem by 2.6% during the 3rd quarter. Xponance Inc. now owns 36,754 shares of the industrial products company’s stock valued at $3,346,000 after acquiring an additional 938 shares during the period. Institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

Shares of Xylem stock opened at $132.60 on Tuesday. The stock has a 50 day moving average of $127.91 and a 200 day moving average of $114.34. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $133.34. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. The firm has a market cap of $32.14 billion, a PE ratio of 48.75, a PEG ratio of 2.64 and a beta of 1.10.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.05 billion. During the same quarter in the prior year, the firm posted $0.92 EPS. Xylem’s quarterly revenue was up 40.6% compared to the same quarter last year. On average, research analysts expect that Xylem Inc. will post 4.13 EPS for the current fiscal year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a $0.36 dividend. The ex-dividend date was Tuesday, February 20th. This is an increase from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 1.09%. Xylem’s payout ratio is presently 52.94%.

Insider Activity at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on XYL shares. Citigroup boosted their price target on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research report on Monday, April 8th. Royal Bank of Canada raised their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Wednesday, February 7th. BNP Paribas began coverage on shares of Xylem in a research note on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 target price on the stock. Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a report on Thursday, January 4th. Finally, Oppenheimer lifted their price target on shares of Xylem from $133.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, April 18th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $138.11.

Check Out Our Latest Research Report on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.